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We welcome the recent systematic review by Andrade et al. [1], who explored in a detailed manner 
the question of whether the acute:chronic workload ratio (ACWR) is associated with risk of 
time‑ loss injury in professional team sports. Including their paper, there are now at least four 
systematic reviews published on this topic over the last two years [1-4]. Despite this number of 
evidence syntheses, we would like to highlight the worrying degree of inconsistency in conclusions 
between these reviews. While there are some differences between reviews in the selected study 
population, we question whether it is heterogeneity in the various appraisals of study quality that 
best explains the inconsistency in conclusions. 
 
In Table 1, we present information on studied population, study quality appraisal details and the 
overall conclusions (derived primarily from the abstract and discussion sections) for each systematic 
review. Although a somewhat basic metric, we attempted to convert all the study quality ratings into 
percentage ratings, knowing the minimum and maximum number of items that were reported for 
each rating tool. In some reviews, quality scores were already reported as percentages. It can be 
seen that there is large variability between the average and range of percentage quality ratings in 
each review. Nevertheless, it can be seen that the review in which the most “negative” conclusion 
was arrived at [4] is also associated with the lowest average percentage rating across the studies. 
However, we also highlight that the quality tool employed by Wang et al. [4] also contained the least 
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number of items. It is, however, striking how different the conclusions of Wang et al. [4] are, 
compared with those in the other reviews. 
 
Quality ratings for individual studies were not reported by Maupin et al. [3]. Nevertheless, in Table 2, 
we present the individual study quality ratings for four studies that were included in the other 
systematic reviews. Again, the variability in study quality rating is striking, ranging from all items 
being realised (100%) for one study [5] in one systematic review [2] to a very low quality rating for 
the same study in another systematic review [4]. It is also unclear in most systematic reviews 
whether a threshold quality rating was arrived at in an a priori manner to inform whether a particular 
study should be included or not. A priori decisions like this have been reported to be paramount for 
rating the stability and strength of evidence in systematic reviews [6]. 
 
In one review [3], an overall rating of ‘fair’ changed to ‘good’ when items deemed not to be relevant 
were removed from the quality tool that had already been modified. It can be seen that different 
study quality rating tools were used, as well as modified, by the various reviewers. Although the 
Downs and Black tool used in two reviews [1, 3] is designed to appraise the quality of randomised 
or non-randomised studies, the tool was designed specifically for intervention studies [7]. It is, 
therefore, not surprising that this tool needed to be modified by the researchers to appraise the 
quality of the various studies. The studies that have been reviewed are more akin to observational 
cohort studies rather than intervention studies, although there is also a within-subject change aspect 
to the ACWR exposure. Assuming that simple ratio assumptions are satisfied, the relevant question 
is whether a change (within players over time) in the ACWR is a useful predictive exposure for injury 
risk [8]. Validated tools for observational study designs are available, e.g., the National Institutes of 
Health Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies [9]. We, 
therefore, suggest that a substantial source of variability that may have influenced the conclusions 
of some of the systematic reviews is the choice of the most appropriate study quality tool, and the 




































































The replication of study findings is an increasingly important issue in research. From the evidence 
syntheses on the ACWR that have been published over the last two years, the conclusions seem to 
range from the ACWR metric being “valuable” to having serious “limitations” in terms of association 
to future injury risk. We congratulate Andrade and colleagues for appraising, in such a 
comprehensive manner, study quality, although their choice of measurement tool (designed for 
intervention studies) meant that substantial modifications were needed – as was the case for 
another review [3]. While several factors can influence discordance between systematic reviews 
[10], we maintain that variability between reviews in study quality tools, and how they are modified 
and interpreted are fundamental issues that may explain the variability in review conclusions on this 
particular topic. To arrive at a consistent and appropriate rating tool and threshold for acceptable 
study quality, we encourage researchers to collaborate on this matter. 
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Table 1. Summary of the study appraisals reported in the various systematic reviews on the topic of the ACWR and injury risk. For the “Primary 
































The quality of 21 studies 
was classified as ‘good’ 
and one study was 
classified as ‘fair’. The 
quality was generally 
described as being 
“very high” 
“The findings of this review 
support the use of the ACWR as 
a valuable tool for monitoring 
training load as part of a larger 
scale multifaceted monitoring 






27 Modified Downs 
and Black 














The mean study quality 
was first reported to be 
‘fair’. When the quality 
appraisal tool was 
further modified* to 
remove items relating to 
intervention studies, the 
average study quality 
was then reported as 
‘good’. 
“The findings of this review 
support the association between 
the ACWR and non-contact 
injuries and its use as a valuable 
tool for monitoring training load 
as part of a larger scale 
multifaceted monitoring system 
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and Black 












reported. The majority 
of studies lacked 
information about 
players transferring 
between teams, missing 
data, adjustment of 
confounders and 
sample size.  
“The majority of studies suggest 
that athletes are at greater risk of 
sustaining a time-loss injury 
when the ACWR is higher 
relative to a lower or moderate 
ACWR. The heterogeneous 
methodological approaches not 
only reflect the wide range of 
sports studied and the differing 
demands of these activities, but 
















All studies were 
deemed to be of “poor” 
quality. 
“These findings fall in line with 
the growing evidence 
demonstrating the limitations of 
ACWR as a metric for 




































































Table 2. Study quality ratings (%) reported in the various systematic reviews for the four studies that were included in all reviews 
 
 Delecroix et al. [5] Jaspers et al. [11] McCall et al. [12] Malone et al. [13] 
Griffin et al. [2] 100 89 89 78 
Andrade et al. [1] 75 75 81 69 
Wang et al. [4] 43 29 57 29 
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